ABBREVIATIONS
Ψ, pseudouridine; A-to-I, Adenosine-to-Inosine; AML, Acute Myeloid Leukaemia; AZA, 5-azacytidine; CDS, coding regions; CML, chronic myeloid leukaemia; CTCL, cutaneous T-cell lymphoma; DNMT, DNA methyltransferases; ESCC, oesophageal squamous cell carcinoma; EMT, epithelial-mesenchymal transition; GBM, glioblastoma multiforme; HCC, hepatocellular carcinoma; HDAC, histone desacetylases; hm5C, 5‑hydroxylmethyl cytidine; HMT, histone methyltransferases; HNSCC, Head and Neck Squamous Carcinoma KMT, lysine protein methyltransferases; m1A, N1-methyladenosine; m5C, 5‑methyl cytidine; m6A, N6-methyladenosine; MA, meclofenamic acid; MA2, ethyl ester form of meclofenamic acid;MDS, myelodysplastic syndrome; MM, multiple myeloma; mRNA, messenger RNA; miRNA, microRNA ncRNA, non-coding RNA; NSCLC, non-small cell lung cancer; PDX, patient-derived xenograft; PTCL, peripheral T-cell lymphoma; rRNA, ribosomal RNA; SAM, S-adenosylmethionine; tRNA, transfer RNA; UTR, untranslated regions.